NEW YORK — Roche Diagnostics recently took over development of a proof-of-principle prototype that could become a model for future point-of-care platforms, according to Christian Tidona, founder and managing director of Heidelberg, Germany-based BioMed X.
Specifically, Roche has taken on development of a multimodal diagnostic platform invented and developed by scientists at the BioMed X Innovation Center in Heidelberg. If Roche is successful, the platform could enable testing for several conditions in one setting and provide an alternative to laboratory tests, Tidona added.